Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
Griffiths M, Yang J, Nies M, Vaidya D, Brandal S, Williams M, Matsui EC, Grant T, Damico R, Ivy D, Austin ED, Nichols WC, Pauciulo MW, Lutz K, Rosenzweig EB, Hirsch R, Yung D, Everett AD. Griffiths M, et al. Among authors: yung d. Pediatr Res. 2020 Dec;88(6):850-856. doi: 10.1038/s41390-020-01113-x. Epub 2020 Sep 14. Pediatr Res. 2020. PMID: 32927467 Free PMC article.
Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network.
Handler SS, Varghese NP, Rosenzweig EB, Yung D, Krishnan U, Whalen E, Bates A, Avitabile CM, Jackson EO, Hirsch R, Fineman J, Abman SH; Pediatric Pulmonary Hypertension Network (PPHNet). Handler SS, et al. Among authors: yung d. Pulm Circ. 2022 Feb 15;12(1):e12031. doi: 10.1002/pul2.12031. eCollection 2022 Jan. Pulm Circ. 2022. PMID: 35506071 Free PMC article.
An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease.
Varghese NP, Austin ED, Galambos C, Mullen MP, Yung D, Guillerman RP, Vargas SO, Avitabile CM, Chartan CA, Cortes-Santiago N, Ibach M, Jackson EO, Jarrell JA, Keller RL, Krishnan US, Patel KR, Pogoriler J, Whalen EC, Wikenheiser-Brokamp KA, Villafranco NM, Hopper RK, Usha Raj J, Abman SH; Pediatric Pulmonary Hypertension Network (PPHNet). Varghese NP, et al. Among authors: yung d. Eur Respir J. 2024 Sep 26;64(3):2400639. doi: 10.1183/13993003.00639-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 39147412 Free PMC article. Review.
Effects of long-term bosentan in children with pulmonary arterial hypertension.
Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ. Rosenzweig EB, et al. Among authors: yung d. J Am Coll Cardiol. 2005 Aug 16;46(4):697-704. doi: 10.1016/j.jacc.2005.01.066. J Am Coll Cardiol. 2005. PMID: 16098438 Free article.
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).
Beghetti M, Schulze-Neick I, Berger RM, Ivy DD, Bonnet D, Weintraub RG, Saji T, Yung D, Mallory GB, Geiger R, Berger JT, Barst RJ, Humpl T; TOPP Investigators. Beghetti M, et al. Among authors: yung d. Int J Cardiol. 2016 Jan 15;203:325-30. doi: 10.1016/j.ijcard.2015.10.087. Epub 2015 Oct 23. Int J Cardiol. 2016. PMID: 26583838
167 results